Pharmaceutical Executive, Oct 1, 2009 - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Pharmaceutical Executive, Oct 1, 2009
Pick a different issue
Features
Are You Ready For The Revolution?
By IMS Health , IMS Health Intelligence.360 Editorial Board
Seven Global Trends shaping the future of the pharmaceutical industry.
Innovation Over Imitation
By Bassil Dahiyat
As the first generation of biologics patents expire, companies are jokeying for position in follow-on biologics.
The Book on Daniel
By Walter Armstrong
Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?
Finding the Sweet Spot
By Gen Li
How proper site activation and site enrollment can help you get the most from clinical trials.
Columns
Making Big Waves
By Peter H. Nalen
How a small competitor benefited from the use of interactive marketing.
Innovation By Design
Executives should embrace design to discover new markets and find new ways to server customers.
Back Page
Animal Testing: Terrorism and the Militant Fringe
The militant fringe of animal rights activists targets pharma.
From the Editor
Explaining Innovation
Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.
Column
End the "Hard Stop"
By Sander A. Flaum
Leaders manage their time and focus their resources by limiting unwanted interruptions.
Think Different
By Stan Bernard, MD
Game-changers can create competitive advantages for pharmaceutical companies and products.
Washington Report
Science and Safety
By Jill Wechsler
All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.

ADVERTISEMENT

Click here